| Identification | |
| Name: | Ethanesulfonic acid,2-[[(3a,5b,7b)-3,7-dihydroxy-24-oxocholan-24-yl]amino]- |
| Synonyms: | tauroursodeoxycholate Sodium;Taurine,N-(3a,7b-dihydroxy-5b-cholan-24-oyl)- (8CI);Tauroursodeoxycholic acid (6CI,7CI);3a,7b-Dihydroxy-5b-cholanoyltaurine;UR 906;Ursodeoxycholyltaurine; |
| CAS: | 14605-22-2 |
| Molecular Formula: | C26H45NO6S |
| Molecular Weight: | 499.7036 |
| InChI: | InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20?,21?,22+,24?,25+,26-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.216 g/cm3 |
| Water Solubility: | 10 mg/ml in water |
| Solubility: | 10 mg/ml in water |
| Appearance: | White solid |
| Usage: | Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways |
| Safety Data | |
 |
|
